Enzalutamide CAS NO 915087-33-1 Inquire about Enzalutamide 

Tecoland supplies Enzalutamide bulk active pharmaceutical ingredient (API) to the pharmaceutical industry. Our Enzalutamide is manufactured by cGMP compliant facility. Welcome to contact us for further details including current DMF status for the product and up to date regulatory status of the manufacturing facility. We look forward to assisting you with your research and development projects.
What is Enzalutamide

Enzalutamide is a prescription medicine used to treat prostate cancer in men who have received surgery or hormone therapy to lower testosterone.

Enzalutamide is sometimes used when the cancer no longer responds to treatment, but has not spread to other parts of the body.

Enzalutamide is also used when the cancer has responded to treatment and has spread to other parts of the body (metastatic).

It is not known if enzalutamide is safe and effective in children or females.

Warnings

Although not for use by women, enzalutamide can cause birth defects if the mother or the father is taking this medicine. Use a condom and one other form of birth control to prevent pregnancy while using this medicine, and for at least 3 months after your last dose.

Before taking this medicine

You should not use enzalutamide if you are allergic to it.

To make sure enzalutamide is safe for you, tell your doctor if you have ever had:

  • a seizure;
  • a head injury, stroke, or brain tumor;
  • heart disease, circulation problems;
  • high blood pressure;
  • diabetes; or
  • high cholesterol or triglycerides (a type of fat in the blood).

Enzalutamide can harm an unborn baby or cause birth defects, even if the father is taking this medicine.

  • If your sex partner is pregnant, always use a condom during sex.
  • If your sex partner could become pregnant, use effective birth control to prevent pregnancy. Keep using birth control for at least 3 months after you stop taking enzalutamide.
  • Tell your doctor at once if a pregnancy occurs while you are taking this morning.

Although this medicine is not for use by women, enzalutamide should not be taken by a woman who is breastfeeding a baby.

Enzalutamide Side Effects

Stop taking this medicine and get emergency medical help if you have signs of an allergic reaction to enzalutamide: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Stop using enzalutamide and call your doctor at once if you have:

  • dizziness, spinning sensation;
  • a seizure (black-out or convulsions);
  • confusion, thinking problems, severe headache, vision problems;
  • weakness, loss of consciousness;
  • red or pink urine;
  • heart problems – chest pain, shortness of breath (even with mild exertion);
  • increased blood pressure – severe headache, blurred vision, pounding in your neck or ears, anxiety, nosebleed; or
  • signs of a lung infection – fever, cough with yellow or green mucus, stabbing chest pain, wheezing, feeling short of breath.

Your cancer treatments may be delayed or permanently discontinued if you have certain side effects.

Common enzalutamide side effects may include:

  • feeling weak or tired;
  • constipation, diarrhea;
  • loss of appetite;
  • flushing (redness, hot feeling);
  • back pain, joint pain; or
  • high blood pressure.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Drug Interaction

Enzalutamide can increase your risk of having a seizure, especially if you also use certain other medicines for infections, swelling or inflammation, asthma, hormone replacement, diabetes, depression, or mental illness.

Many drugs can interact with enzalutamide. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed here. Tell your doctor about all your current medicines and any medicine you start or stop using.

Disclaimer:

Information on this page is provided for general information purposes. You should not make a clinical treatment decision based on information contained in this page without consulting other references including the package insert of the drug, textbooks and where relevant, expert opinion. We cannot be held responsible for any errors you make in administering drugs mentioned on this page, nor for use of any erroneous information contained on this page.